Activity of beta-lactamase inhibitors against Acinetobacter baumannii
Fernández Cuenca, F.
Revista Espanola de Quimioterapia Publicacion Oficial de la Sociedad Espanola de Quimioterapia 11(4): 384-385
1998
ISSN/ISBN: 0214-3429 PMID: 10336325 Document Number: 494886
Document emailed within 1 workday
Related Documents
Yang, C.; Yan, Y.-f.; Wang, G.-q.; Tan, Y.-f. 2011: Multi-locus sequence typing of multidrug-resistant of Acinetobacter baumannii from China and characterization of population structure of Acinetobacter baumannii Zhonghua Yu Fang Yi Xue Za Zhi 45(8): 727-731Jacobs, M.R.; Aronoff, S.C.; Johenning, S.; Shlaes, D.M.; Yamabe, S. 1986: Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli Antimicrobial Agents and Chemotherapy 29(6): 980-985
Chen, C.H.; Yang, M.H.; Lin, J.S.; Lee, Y.C.; Perng, R.P. 1995: The in vitro activity of beta-lactamase inhibitors in combination with cephalosporins against M. tuberculosis Proceedings of the National Science Council Republic of China. Part B Life Sciences 19(2): 80-84
Martin, M.A.; Liebana, J.; Castillo, A.M.; Gutierrez, J.; Piédrola, G. 1991: A comparative study of the activity of first and second generation cephalosporins and their combinations with beta-lactamase inhibitors against Bacteroides fragilis Microbios 67: 272-273
Thamlikitkul, V.; Tiengrim, S.; Seenama, C. 2014: In vitro activity of polymyxin B against carbapenem-resistant Acinetobacter baumannii Journal of the Medical Association of Thailand 97(12): 1254-1258
Pongpech, P.; Amornnopparattanakul, S.; Panapakdee, S.; Fungwithaya, S.; Nannha, P.; Dhiraputra, C.; Leelarasamee, A. 2010: Antibacterial activity of carbapenem-based combinations againts multidrug-resistant Acinetobacter baumannii Journal of the Medical Association of Thailand 93(2): 161-171
Thamlikitkul, V.; Tiengrim, S. 2014: In vitro activity of colistin plus sulbactam against extensive-drug-resistant Acinetobacter baumannii by checkerboard method Journal of the Medical Association of Thailand 97 Suppl. 3: S1-S6
Sinha, M.; Srinivasa, H.; Macaden, R. 2007: Antibiotic resistance profile and extended spectrum beta-lactamase (ESBL) production in Acinetobacter species Indian Journal of Medical Research 126(1): 63-67
Tiengrim, S.; Tribuddharat, C.; Thamlikitkul, V. 2006: In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand Journal of the Medical Association of Thailand 89(Suppl 5): S102-S105
Triantafilo, V.; Fica, A.; Silva, M.; Thompson, L. 1997: E-test to study small inhibitor concentrations, bacterial diversity and to identify presumptively beta-lactamases in strains of Pseudomonas aeruginosa and Acinetobacter baumannii associated with +nosocomial infections Revista Medica de Chile 125(2): 149-160
Alós, J.I.; Oteo, J. 1999: Resistance to the combination of beta-lactams and beta-lactamase inhibitors Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 12(3): 205-210
Amicosante, G.; Felici, A.; Segatore, B.; di Marzio, L.; Franceschini, N.; di Girolamo, M. 1989: Do inert beta-lactamase inhibitors act as synergizers of beta-lactam antibiotics? Utility of boric and boronic acids Journal of ChemoTherapy 1(6): 394-398
Maiti, S.N.; Phillips, O.A.; Micetich, R.G.; Livermore, D.M. 1998: Beta-lactamase inhibitors: agents to overcome bacterial resistance Current Medicinal Chemistry 5(6): 441-456
Stewardson-Krieger, P.; Naidu, S. 1981: Simultaneous recovery of beta-lactamase-negative and beta-lactamase-positive Haemophilus influenzae type b from cerebrospinal fluid of a neonate Pediatrics 68(2): 253-254
Bayraktar, B.; Toksoy, B.; Bulut, E. 2010: Detection of bla(CTX-M) beta-lactamase genes in extended-spectrum beta-lactamase producing gram-negative bacteria Mikrobiyoloji Bulteni 44(2): 187-196
Baykal, A.; Cöplü, N.; Simşek, H.üs.; Esen, B.; Gür, D. 2012: The presence of extended spectrum beta-lactamase, KPC-type carbapenemase and plasmid-mediated AmpC beta-lactamase in E.coli and K.pneumoniae strains isolated from blood cultures Mikrobiyoloji Bulteni 46(2): 159-169
Kuga, A.; Yano, H.; Okamoto, R.; Sato, Y.; Miyata, A.; Inoue, M. 1999: Antibacterial activity of beta-lactam antibiotics against extended-spectrum beta-lactamase producing bacteria Japanese Journal of Antibiotics 52(9): 585-594
Mikołajczyk, J.; Kotulowa, W.; Kazimierczak, J.; Sikora, A.; Rogowska, W.; Cieślak, J. 1980: Beta-lactamase inhibitors. I. Synthesis and biological properties of penicillanic acid derivatives Acta Poloniae Pharmaceutica 37(6): 637-641
Jarlier, V. 1998: Beta-lactamase producers and other bacteria: which ones to take into consideration and when? the concept of beta-lactamase inhibitor Presse Medicale 27(Suppl 4): 17-18
O'hara, K.; Shiomi, Y.; Kono, M. 1983: Comparative study of the activities of beta lactamase inhibitors by nuclear magnetic resonance spectrometry Japanese Journal of Antibiotics 36(10): 2763-2768